Nerandomilast in Patients with Idiopathic Pulmonary FibrosisLuca Richeldi, Marlies Wijsenbeek, Justin M. Oldham et al.|New England Journal of Medicine|2025Cited by 159
Nerandomilast in Patients with Progressive Pulmonary FibrosisToby M. Maher, Fernando J. Martínez, Shervin Assassi et al.|New England Journal of Medicine|2025Cited by 134
A Randomized, Embedded, Multifactorial Adaptive Platform trial for ILD (REMAP-ILD): The conceptual designTejaswini Kulkarni, Gísli Jenkins, Letícia Kawano-Dourado et al.|Unknown|2023Cited by 2